Brief: Cyxone Revises Development Plan For Rabeximod

Cyxone AB

25/09/2020 08:22

Sept 25 (Reuters) - Cyxone AB  CYXO.ST :
    * SAID ON THURSDAY REVISES THE DEVELOPMENT PLAN FOR
RABEXIMOD
    * CO IS PREPARING A PHASE 2 CLINICAL STUDY OF RABEXIMOD IN
COVID-19 PATIENTS, WITH A POTENTIAL INITIATION ALREADY IN Q4 OF
2020
    * CYXONE - TRIAL IS EXPECTED TO INCLUDE 300 PATIENTS, WILL
BE
CONDUCTED IN A NUMBER OF EUROPEAN COUNTRIES WITH EXPECTED
READOUT IN Q3 OF 2021

Source text for Eikon:  ID:nWkr9NTp1Q 
Further company coverage:  CYXO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))